Skip to main content

and
  1. Article

    Open Access

    Effect of Regdanvimab on Mortality in Patients Infected with SARS-CoV-2 Delta Variants: A Propensity Score-Matched Cohort Study

    Regdanvimab, a monoclonal antibody pharmaceutical, is the first Korean drug approved for treating coronavirus disease 2019 (COVID-19). We analyzed the therapeutic efficacy of regdanvimab in patients with the C...

    Soyoon Hwang, Nan Young Lee, Eunkyung Nam, Yu Kyung Kim in Infectious Diseases and Therapy (2024)

  2. Article

    Open Access

    Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea

    Regdanvimab, a neutralising monoclonal antibody (mAb) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), received approval for the treatment of coronavirus disease 2019 (COVID-19) in South K...

    Ji Yeon Lee, Seon Hee Bu, EunHyang Song, Seongcheol Cho in Infectious Diseases and Therapy (2023)

  3. Article

    Open Access

    Relationship between the appropriateness of antibiotic treatment and clinical outcomes/medical costs of patients with community-acquired acute pyelonephritis: a multicenter prospective cohort study

    Inappropriate use of antibiotics not only increases antibiotic resistance as collateral damage but also increases clinical failure rates and medical costs. The purpose of this study was to determine the relati...

    Choseok Yoon, Se Yoon Park, Bongyoung Kim, Ki Tae Kwon in BMC Infectious Diseases (2022)

  4. Article

    Open Access

    Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea

    As the coronavirus disease 2019 (COVID-19) pandemic continues to progress, awareness about its long-term impacts has been growing. To date, studies on the long-term course of symptoms, factors associated with ...

    Yoonjung Kim, Bitna-Ha, Shin-Woo Kim, Hyun-Ha Chang, Ki Tae Kwon in BMC Infectious Diseases (2022)

  5. Article

    Open Access

    Clinical outcomes and healthcare costs of inpatients with tetanus in Korea, 2011–2019

    Tetanus is a rare, vaccine-preventable but extremely serious disease. We investigated the recent trend of the clinical outcomes and medical costs for inpatients with tetanus in South Korea over 10 years.

    Sohyun Bae, Minsik Go, Yoonjung Kim, Soyoon Hwang, Shin-Woo Kim in BMC Infectious Diseases (2021)

  6. No Access

    Article

    Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease

    We aimed to elucidate the potential impact of gender on prognosis of Staphylococcus aureus bacteremia (SAB). We analyzed SAB cases prospectively collected over an 8-year period at 11 hospitals in Korea. SAB-relat...

    Chang Kyung Kang, Yee Gyung Kwak in European Journal of Clinical Microbiology … (2018)

  7. Article

    Open Access

    Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific

    Herpes zoster (HZ) is a prevalent viral disease that inflicts substantial morbidity and associated healthcare and socioeconomic burdens. Current treatments are not fully effective, especially among the most vu...

    Liang-Kung Chen, Hidenori Arai, Liang-Yu Chen, Ming-Yueh Chou in BMC Infectious Diseases (2017)

  8. No Access

    Article

    Predictive risk factors for Listeria monocytogenes meningitis compared to pneumococcal meningitis: a multicenter case–control study

    Various immunocompromised conditions increase the risk of meningitis caused by Listeria monocytogenes. However, the relative importance of these risk factors has not been well established. We determined the risk ...

    Seung** Lim, Doo Ryeon Chung, Yeon-Sook Kim, Kyung Mok Sohn, Seung-Ji Kang in Infection (2017)

  9. Article

    Open Access

    Catheter-associated bacteremia by Mycobacterium senegalense in Korea

    Rapidly growing mycobacteria is recognized as one of the causative agents of catheter-related infections, especially in immunocompromised hosts. To date, however, Mycobacterium senegalense, which was known as the...

    Won Sup Oh, Kwan Soo Ko, Jae-Hoon Song, Mi Young Lee in BMC Infectious Diseases (2005)